ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

Biomarkers are the only feasible way to detect and monitor presymptomatic Alzheimer's disease (AD). No single biomarker can predict future cognitive decline with an acceptable level of accuracy. In addition to designing powerful multimodal diagnostic platforms, a careful investigation of the ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolova, Liana G., Hwang, Kristy S., Kohannim, Omid, Avila, David, Elashoff, David, Jack, Clifford R., Shaw, Leslie, Trojanowski, John Q., Weiner, Michael W., Thompson, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952354/
https://www.ncbi.nlm.nih.gov/pubmed/24634832
http://dx.doi.org/10.1016/j.nicl.2013.12.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952354/
https://www.ncbi.nlm.nih.gov/pubmed/24634832
http://dx.doi.org/10.1016/j.nicl.2013.12.012

Ejemplares similares